Financials
Financial year 2025
Pharma Universalis from Herent, company number BE1004253371, closed financial year 2025 with a result of € 45,822 after tax. For that financial year Pharma Universalis recorded a gross margin of € 59,622 and equity of € 94,403. Compared with financial year 2024, the result moved from € 43,581 to € 45,822. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 28, 2026.
€ 94,403
▲ 94% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 45,822
▲ 5% vs 2024
Profit after tax over the fiscal year.
€ 111,704
▲ 112% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 89,403.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 4,988
▼ 21% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 39
▼ 43% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 33,674
▲ 56% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € 57,319 | € 59,622 | ▲ 4% |
| Profit after taxes | € 43,581 | € 45,822 | ▲ 5% |
| Equity | € 48,581 | € 94,403 | ▲ 94% |
| Total debts | € 22,725 | € 34,795 | ▲ 53% |
| Cash | € 52,786 | € 111,704 | ▲ 112% |
| Retained profit | € 43,581 | € 89,403 | ▲ 105% |
| Balance sheet total | € 71,306 | € 129,198 | ▲ 81% |
Key figures of Pharma Universalis, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Pharma Universalis?
What happened at Pharma Universalis in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 45,822 (▲ 5% vs 2024). Source: NBB ↗
- New establishment in Zemst. KBO
- Koen Peeters became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 43,581 profit in 2024 to € 45,822 profit in 2025.
Paid € 23,765 in corporate taxes since 2024.
Best year ever: 2025, with € 45,822 profit.
A new publication or filing at Pharma Universalis? We notify you, reason included.
Follow Pharma UniversalisDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Pharma Universalis is Koen Peeters. Koen Peeters is also behind Apotheek Verbist.
Directors
According to the 2025 annual accounts
since 2024
Establishments
Establishment units
Physical locations of this company
Kerkweg 20
3020 Herent
Brusselsesteenweg 390
1980 Zemst
Active since 4 January 2024
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1004.253.371
- VAT number
- BE 1004.253.371
- Registered office
- Kerkweg 20, 3020 Herent
- Names & denominations
- Pharma Universalis
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 4 January 2024
- Peppol
- Active · Active since 27 Mar 2025
- Activities · NACE
Overige zakelijke dienstverlening, neg
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige persoonlijke diensten
Activiteiten van hoofdkantoren
Overige dienstverlenende activiteiten op het gebied van informatie
Handelsbemiddeling in de niet-gespecialiseerde groothandel
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Overige dienstverlenende activiteiten op het gebied van informatie, n.e. g.